170 related articles for article (PubMed ID: 9707604)
1. Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking.
Scheipers P; Reiser H
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10083-8. PubMed ID: 9707604
[TBL] [Abstract][Full Text] [Related]
2. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
Krummel MF; Allison JP
J Exp Med; 1996 Jun; 183(6):2533-40. PubMed ID: 8676074
[TBL] [Abstract][Full Text] [Related]
3. Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death.
Wekerle T; Kurtz J; Sayegh M; Ito H; Wells A; Bensinger S; Shaffer J; Turka L; Sykes M
J Immunol; 2001 Feb; 166(4):2311-6. PubMed ID: 11160287
[TBL] [Abstract][Full Text] [Related]
4. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells.
Chen W; Jin W; Wahl SM
J Exp Med; 1998 Nov; 188(10):1849-57. PubMed ID: 9815262
[TBL] [Abstract][Full Text] [Related]
5. Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals.
Katsikis PD; García-Ojeda ME; Wunderlich ES; Smith CA; Yagita H; Okumura K; Kayagaki N; Alderson M; Herzenberg LA; Herzenberg LA
Int Immunol; 1996 Aug; 8(8):1311-7. PubMed ID: 8918700
[TBL] [Abstract][Full Text] [Related]
6. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.
Waterhouse P; Penninger JM; Timms E; Wakeham A; Shahinian A; Lee KP; Thompson CB; Griesser H; Mak TW
Science; 1995 Nov; 270(5238):985-8. PubMed ID: 7481803
[TBL] [Abstract][Full Text] [Related]
7. Cyclic adenosine 5'-monophosphate and calcium induce CD152 (CTLA-4) up-regulation in resting CD4+ T lymphocytes.
Vendetti S; Riccomi A; Sacchi A; Gatta L; Pioli C; De Magistris MT
J Immunol; 2002 Dec; 169(11):6231-5. PubMed ID: 12444128
[TBL] [Abstract][Full Text] [Related]
8. Control of CD4 T cell fate by antigen re-stimulation with or without CTLA-4 engagement 24 h after priming.
Nakata Y; Uzawa A; Suzuki G
Int Immunol; 2000 Apr; 12(4):459-66. PubMed ID: 10744647
[TBL] [Abstract][Full Text] [Related]
9. Regulation of T cell activation by CD28 and CTLA4.
Noel PJ; Boise LH; Thompson CB
Adv Exp Med Biol; 1996; 406():209-17. PubMed ID: 8910687
[TBL] [Abstract][Full Text] [Related]
10. Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor.
Scheipers P; Reiser H
Immunol Res; 1998; 18(2):103-15. PubMed ID: 9844829
[TBL] [Abstract][Full Text] [Related]
11. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
Wells AD; Walsh MC; Bluestone JA; Turka LA
J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
[TBL] [Abstract][Full Text] [Related]
12. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells.
Chambers CA; Sullivan TJ; Allison JP
Immunity; 1997 Dec; 7(6):885-95. PubMed ID: 9430233
[TBL] [Abstract][Full Text] [Related]
13. Activation-mediated CD4+ T cell unresponsiveness during acute Toxoplasma gondii infection in mice.
Khan IA; Matsuura T; Kasper LH
Int Immunol; 1996 Jun; 8(6):887-96. PubMed ID: 8671678
[TBL] [Abstract][Full Text] [Related]
14. Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells.
Wang XB; Zheng CY; Giscombe R; Lefvert AK
Scand J Immunol; 2001 Nov; 54(5):453-8. PubMed ID: 11696196
[TBL] [Abstract][Full Text] [Related]
15. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.
Metz DP; Farber DL; Taylor T; Bottomly K
J Immunol; 1998 Dec; 161(11):5855-61. PubMed ID: 9834064
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells.
Iida T; Ohno H; Nakaseko C; Sakuma M; Takeda-Ezaki M; Arase H; Kominami E; Fujisawa T; Saito T
J Immunol; 2000 Nov; 165(9):5062-8. PubMed ID: 11046036
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.
Hurwitz AA; Yu TF; Leach DR; Allison JP
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10067-71. PubMed ID: 9707601
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar.
Gomes NA; Gattass CR; Barreto-De-Souza V; Wilson ME; DosReis GA
J Immunol; 2000 Feb; 164(4):2001-8. PubMed ID: 10657651
[TBL] [Abstract][Full Text] [Related]
19. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
Mukherjee S; Maiti PK; Nandi D
J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses.
Chambers CA; Kuhns MS; Allison JP
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8603-8. PubMed ID: 10411922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
